SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000929638-10-000576
Filing Date
2010-08-24
Accepted
2010-08-24 16:11:53
Documents
2
Group Members
GEORGE L. BALLJAMES C. GALEJOYCE ERONYLIFE SCIENCES OPPORTUNITIES FUND (INSTITUTIONAL) II, L.P.SANDERS MORRIS HARRIS GROUP, INC.SANDERS MORRIS HARRIS INC. (FORMERLY SMH CAPITAL INC.)SIGNET HEALTHCARE PARTNERS, LLC

Document Format Files

Seq Description Document Type Size
1 SC13D/A3 IGI LABORATORIES, INC. 08/24/2010 igilaboratories_sch13da3.htm SC 13D/A 207051
2 EX1 JOINT FILING AGREEMENT AM3 igi_ex1a3.htm EX-99.3 16883
  Complete submission text file 0000929638-10-000576.txt   226331
Mailing Address 105 LINCOLN AVENUE BUENA NJ 08310
Business Address 105 LINCOLN AVENUE BUENA NJ 08310 6096971441
IGI LABORATORIES, INC (Subject) CIK: 0000352998 (see all company filings)

IRS No.: 010355758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-34057 | Film No.: 101035334
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 126 E 56TH STREET 28TH FL NEW YORK NY 10022
Business Address 126 EAST 56TH STREET NEW YORK NY 10022 212-419-3900
LIFE SCIENCES OPPORTUNITIES FUND II LP (Filed by) CIK: 0001269415 (see all company filings)

IRS No.: 571190948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A